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Heart failure is one of the leading causes of mortality and morbidity in the world. Heart transplantation is still the
gold standard therapy despite emerging treatment options. Due to the limited number of available donors, the use of
ventricular assist devices has increased. However, increasing incidences of complications are observed with using these
devices. In this article, surgical treatment of a huge mobile thrombus formation in an inflow cannula due to ineffective
anticoagulation in a 59 year-old man who received a HeartWare ventricular assist device because of ischemic
cardiomyopathy is presented.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The use of a left ventricular assist device(LVAD) in the management of advanced
heart failure has grown in recent years.
Thrombosis of LVADs is a potentially lethal com-
plication, as it usually results either in the need for
urgent transplantation, LVAD replacement, or
death. Device thrombosis incidence is 0.02 events
per patient per year [1,2]. Subtherapeutic antico-
agulation is the most common cause of device
thrombosis. Early diagnosis and treatment ofLVAD is important. Device thrombosis is clinically
suspected in the presence of hemolysis, elevated
lactate dehydrogenase (LDH), worsening heart
failure, and/or device malfunction (power spike,
low-flow alarms) [3]. We present a case with
inflow cannula thrombus, due to subtherapeutic
anticoagulation which required surgical
treatment.
Case report
A 59 year-old man with a history of ischemic
cardiomyopathy with an operation of coronary
artery bypass grafting in 2004, presented witheCCBY-
Figure 2. Thrombus formation in the inflow cannula surgically
extracted.
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continuous-flow LVAD for bridging therapy
for cardiac transplantation, and received a
HeartWare System, Framingham, MA, USA,
LVAD 15 months ago. The patient presented to
the cardiology department with ‘‘low flow’’ alarms
for 2 days.
At presentation, he was dyspneic and anxious.
Physical examination showed blood pressure of
90/60 mmHg and a heart rate of 69 beats/min.
Cardiovascular system examination showed
apical 3/6 systolic murmur and S3. Respiratory
system examination showed rales reaching mid
lung zones. Electrocardiography showed atrial
fibrillation 73 beats/min, Q waves in inferior
derivations, and loss of R wave progression in
anterior derivations. The device’s settings were
checked. The pump’s flow rate was an average of
3.5 L/min and the power consumed was an aver-
age of 3.5 watts at the patient’s 468 days of moni-
toring. On presentation, while the pump revved
2600 rpm, the flow rate was between 1 and
1.8 L/min, and the power was an average of
2.5 w. When the log file was examined, there had
been a sudden drop in flow and power 2 days
ago. The patient’s LDH value was 1680 unit/L
and the international normalized ratio value was
found 2.7 at admission. Although the patient’s
international normalized ratio was in the range
of therapeutic values, he had a history of irregular
use of anticoagulants in the previous 2 weeks.
Transthoracic echocardiography was performed,
and the aortic valve opening with every cardiac
cycle and low flow velocity through the inflow
cannula suggesting inadequate unloading of the
left ventricle was seen. Transesophageal echocar-
diography was then performed. Gastric views
showed a mobile huge thrombus formation in
the inflow cannula (Fig. 1). Because of the mobile,Figure 1. A huge thrombus in the inflow cannula.huge thrombus, and unstable condition, surgery
was preferred to thrombolytic therapy. The
patient was referred to the cardiac surgery depart-
ment immediately. Anterolateral thoracotomy
incision was performed from the fifth intercostal
space and the thrombus was detected in the
extracted pump’s inflow cannula (Fig. 2). Pump
replacement was performed successfully by using
a minimal thoracotomy technique. After the oper-
ation, the pump’s flow rate was observed at
3.2 L/min. In the postoperative follow-up periods,
the patient’s hemodynamics showed a stable
pump flow rate of an average of 3.4 L/min and
there were no findings suggestive of obstruction
in the outflow graft. Because the patient’s body
mass index was 21.1, a 3.4 L/min pump flow was
considered to be sufficient for the patient and he
was discharged 2 weeks later.Discussion
Heart failure is one of the leading health prob-
lems because of increasing incidence and preva-
lence worldwide. In 2010, more than 40 million
patients were living with heart failure. According
to 1990 data a 14% increase has been observed.
Globally, 38% of heart failures were caused by
ischemic heart disease. The pattern varies by
region. Ischemic heart disease was responsible
for 61% of heart failure in North America and
50% in Western Europe [4].
Heart transplantation is the gold standard treat-
ment for patients with advanced heart failure. Due
to donor limitation, mechanical circulatory sup-
port is being used increasingly to treat patients
with advanced heart failure as bridge to transplant
therapy or destination therapy. First-generation
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transplant therapy. Pulsatile flow pumps have
been replaced with continuous-flow rotary pumps.
Continuous-flow rotary pumps have been demon-
strated as adequate hemodynamic support and
cause less hemolysis; in addition these pumps
have helped to improve patients’ life quality, due
to their small size [5].
Widespread usage of mechanical support
devices have brought a number of problems.
These problems lead to device dysfunctions, one
of which is a low pump alarm caused by various
mechanisms of cannula obstruction. These
include partial inlet occlusion by adjacent
myocardial trabeculations, cannula angulation
into the myocardium, or other cannula malposi-
tion caused by left ventricular underfilling, inlet
or outlet kinking, and cannula thrombus [6,7].
Echocardiography is mostly an ideal tool to detect
these problems. It is noninvasive, widely avail-
able, and can be performed at the bedside.
LVAD thrombosis is related to increased mor-
bidity and mortality, usually requiring replace-
ment of the device and requires a high level of
clinical suspicion. In a LVAD patient, if there are
new signs or symptoms of heart failure, changes
in the functional capacity, an increase in LDH
levels (a diagnostic marker of hemolysis), and
changes in LVAD parameters, device thrombosis
should be suspected [3]. Additionally, when used
in conjunction with elevated LDH levels, echocar-
diographic ‘‘Ramp test’’ is highly sensitive and
specific in the determination of LVAD thrombosis.
When there is device thrombosis, partial or total
occlusion, there may be a sudden drop in power
and flow. In addition, power and current can be
increased in parallel with the gradual formation
of thrombus [8]. In our case, the patient had wors-
ening heart failure and elevated LDH levels, a
sudden drop in device power, and flow. We sus-
pected LVAD thrombosis and performed trans-
esophageal echocardiography and detected a
huge mobile thrombus in the inflow cannula. As
we saw the inflow cannula thrombus on the
echocardiographic examination, a Ramp test was
not performed. Different strategies are used in
the treatment of continuous and axial flow LVAD
thrombosis, including systemic or intraventricular
thrombolytics or surgical replacement.
Intraventricular thrombolytics were used success-
fully with the axial-flow pumps with a low risk of
hemorrhagic events [2,3,9]. However, pump
replacement despite high morbidity and mortalitycan be performed in unstable patients or those
who have contraindication for thrombolytic
therapy.
Successful treatment of continuous flow LVAD
thrombosis has been noted with thrombolysis
despite the risk of catastrophic hemorrhagic
events, especially intracranial bleeds. In our clinic,
the first approach in hemodynamically stable
patients with pump thrombus is thrombolytic
therapy. However, in this case, the patient was
hemodynamically unstable. So, as the first
approach we preferred pump replacement
because the thrombus was large and mobile, the
symptoms of heart failure were serious, and sev-
ere hypotension was accompanied despite ino-
tropes. After pump replacement, the patient
clinically recovered and was discharged 2 weeks
later.Conclusion
LVAD thrombosis is a serious problem and
treatment must be started immediately. Despite
high risks, surgical treatment is an option for
LVAD thrombosis in unstable patients.
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